We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$79.7B
AUM Growth
-$2.55B
Cap. Flow
-$8.09B
Cap. Flow %
-10.15%
Top 10 Hldgs %
26.07%
Holding
2,483
New
414
Increased
840
Reduced
685
Closed
192

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$892M
2
AAPL icon
Apple
AAPL
+$310M
3
MRVL icon
Marvell Technology
MRVL
+$305M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$233M
5
UNH icon
UnitedHealth
UNH
+$230M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$812M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$445M
3
DIS icon
Walt Disney
DIS
+$312M
4
LH icon
Labcorp
LH
+$296M
5
PNW icon
Pinnacle West Capital
PNW
+$287M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Financials 13.95%
3 Healthcare 12.34%
4 Industrials 9.8%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POOL icon
2201
Pool Corp
POOL
$6.75B
$0 ﹤0.01%
2
– –
PRM icon
2202
Perimeter Solutions
PRM
$4.99B
– –
-10,567
Closed -$78K
PRME icon
2203
Prime Medicine
PRME
$527M
$0 ﹤0.01%
72
-1,042
-94% -$6.32K
PRQR icon
2204
ProQR Therapeutics
PRQR
$243M
$0 ﹤0.01%
276
-3,871
-93% -$7.52K
PVBC
2205
DELISTED
Provident Bancorp
PVBC
$0 ﹤0.01%
+26
New +$240
QURE icon
2206
uniQure
QURE
$3.03B
$0 ﹤0.01%
129
-1,829
-93% -$8.91K
RARE icon
2207
Ultragenyx Pharmaceutical
RARE
$2.45B
$0 ﹤0.01%
37
-4,123
-99% -$176K
RCEL icon
2208
Avita Medical
RCEL
$135M
– –
-5,428
Closed -$87K
LNAI
2209
Lunai Bioworks
LNAI
$8.8M
$0 ﹤0.01%
1
-30
-97% -$4.09K
REX icon
2210
REX American Resources
REX
$1.42B
$0 ﹤0.01%
+10
New +$267
RGNX icon
2211
Regenxbio
RGNX
$620M
$0 ﹤0.01%
119
-1,652
-93% -$25.7K
RGLS
2212
DELISTED
Regulus Therapeutics
RGLS
$0 ﹤0.01%
+122
New +$283
RGP icon
2213
Resources Connection
RGP
$151M
– –
-13,124
Closed -$172K
RIGL icon
2214
Rigel Pharmaceuticals
RIGL
$681M
– –
-328
Closed -$4K
RIVN icon
2215
Rivian
RIVN
$22B
$0 ﹤0.01%
66
-173,192
-100% -$1.81M
ROKU icon
2216
Roku
ROKU
$21.5B
$0 ﹤0.01%
14
-584
-98% -$34.2K
RPAY icon
2217
Repay Holdings
RPAY
$331M
– –
-1,915
Closed -$21K
RYTM icon
2218
Rhythm Pharmaceuticals
RYTM
$6.81B
– –
-1,733
Closed -$75K
SABR icon
2219
Sabre
SABR
$731M
– –
-5,810
Closed -$14K
SANM icon
2220
Sanmina
SANM
$9.95B
– –
-685
Closed -$42K
SBSW icon
2221
Sibanye-Stillwater
SBSW
$6.26B
– –
-23,388
Closed -$110K
SCOR icon
2222
Comscore
SCOR
$106M
– –
-57
Closed –
SEDG icon
2223
SolarEdge
SEDG
$2.51B
$0 ﹤0.01%
9
– –
SGMO
2224
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$0 ﹤0.01%
865
-22,572
-96% -$12.2K
SHEN icon
2225
Shenandoah Telecom
SHEN
$664M
– –
-3,717
Closed -$64K
87 88
89
90 91

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return

Lazard Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Lazard Asset Management held 2,483 positions worth $79.7B, down 3.1% from $82.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $8.09B in Q2 2024, closing 192 positions and reducing 685 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $206M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $105M.

  • Lazard Asset Management's largest Q2 2024 buy was Aspen Technology Inc: 526,997 shares worth $105M.
  • Lazard Asset Management added most to ExxonMobil in Q2 2024, an estimated $892M increase.
  • Lazard Asset Management's biggest Q2 2024 reduction was Chevron, cutting an estimated $812M.
  • Lazard Asset Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $206M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $79.7B portfolio in Q2 2024.
  • Lazard Asset Management opened 414 new positions and closed 192 in Q2 2024.
  • Lazard Asset Management's portfolio value fell 3.1% quarter-over-quarter to $79.7B.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.